Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New N-acetyl-beta-D-glucosaminidase inhibitors identified at Janssen

June 8, 2021

New PPARgamma agonist shows promise in neurodegenerative diseases

June 7, 2021

IMC-1 improves multiple fibromyalgia symptoms

June 7, 2021

PINK1 and Parkin stabilize mutations in mitochondrial DNA

June 4, 2021

Fecal microbiota transplantation used to create autism model in rat offspring

June 4, 2021

Mindset selects its lead next-generation psychedelic candidate, MSP-1014

June 3, 2021

Merck & Co. identifies nicotinic alpha7 receptor PAMs

June 3, 2021

Lophora ApS patents 5-HT2A receptor agonists

June 3, 2021

Encouraging development updates for SupraAntigen-derived liposomal AD vaccine candidates

June 3, 2021

Dana-Farber Cancer Institute presents new PROTACs

June 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...